KJIM :: Korean Journal of Internal Medicine

Citations to this article as recorded by

Research Progress of Diabetic Kidney Disease with Traditional Chinese Medicine

Journal of Contemporary Medical Practice.2024; 6(8): 65. CrossRef

Agomelatine improves streptozotocin-induced diabetic nephropathy through melatonin receptors/SIRT1 signaling pathway

Nevertyty M. Mahmoud, Shimaa M. Elshazly, Arwa A. Hassan, Eman Soliman

International Immunopharmacology.2023; 115: 109646. CrossRef

Novel Therapies for Kidney Disease in People With Diabetes

Nayana Khurana, Steven James, Melinda T Coughlan, Richard J MacIsaac, Elif I Ekinci

The Journal of Clinical Endocrinology & Metabolism.2022; 107(1): e1. CrossRef

Phytomedicine as a source of SGLT2 inhibitors, GLP-1 secretagogues and DPP-IV inhibitors for mitigation of Diabetic Nephropathy

Anuj Kumar Borah, Semim Akhtar Ahmed, Jagat C. Borah

Phytomedicine Plus.2022; 2(2): 100225. CrossRef

Glomerular filtration rate as a kidney outcome of diabetic kidney disease: a focus on new antidiabetic drugs

Hyo Jin Kim, Sang Soo Kim, Sang Heon Song

The Korean Journal of Internal Medicine.2022; 37(3): 502. CrossRef

Berberine protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition involving the inactivation of the NLRP3 inflammasome

Zejun Ma, Lili Zhu, Shangshang Wang, Xin Guo, Bei Sun, Qilong Wang, Liming Chen

Renal Failure.2022; 44(1): 923. CrossRef

Impact of primary aldosteronism on renal function in patients with type 2 diabetes

Sho Katsuragawa, Yuya Tsurutani, Tomoko Takiguchi, Jun Saito, Tetsuo Nishikawa

Journal of Diabetes Investigation.2021; 12(2): 217. CrossRef

Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients With Type 2 Diabetes: A Randomized Trial

Austin G. Stack, Nalina Dronamraju, Joanna Parkinson, Susanne Johansson, Eva Johnsson, Fredrik Erlandsson, Robert Terkeltaub

American Journal of Kidney Diseases.2021; 77(4): 481. CrossRef

Effect of combined therapy of mesenchymal stem cells with GLP-1 receptor agonist, exenatide, on early-onset nephropathy induced in diabetic rats

Heba A. Habib, Gehan H. Heeba, Mohamed M.A. Khalifa

European Journal of Pharmacology.2021; 892: 173721. CrossRef

Geniposide Improves Diabetic Nephropathy by Enhancing ULK1-Mediated Autophagy and Reducing Oxidative Stress through AMPK Activation

Theodomir Dusabimana, Eun Jung Park, Jihyun Je, Kyuho Jeong, Seung Pil Yun, Hye Jung Kim, Hwajin Kim, Sang Won Park

International Journal of Molecular Sciences.2021; 22(4): 1651. CrossRef

Design, synthesis, and biological evaluation of 1,2,4‐oxadiazole‐containing pyrazolo[3,4‐b]pyridinones as a new series of AMPKɑ1β1γ1 activators

Zhihong Xiao, Yajun Peng, Bifeng Zheng, Qi Chang, Yating Guo, Zhuo Chen, Qianbin Li, Gaoyun Hu

Archiv der Pharmazie.2021;[Epub] CrossRef

Mesenchymal Stem Cell-Derived Exosomes Carry MicroRNA-125a to Protect Against Diabetic Nephropathy by Targeting Histone Deacetylase 1 and Downregulating Endothelin-1

Yan Hao, Jie Miao, Wenjia Liu, Kangqin Cai, Xianli Huang, Li Peng

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 1405. CrossRef

Comparative effects of incretin-based therapy on early-onset diabetic nephropathy in rats: Role of TNF-α, TGF-β and c-caspase-3

Heba A. Habib, Gehan H. Heeba, Mohamed M.A. Khalifa

Life Sciences.2021; 278: 119624. CrossRef

Trigonelline induces autophagy to protect mesangial cells in response to high glucose via activating the miR-5189-5p-AMPK pathway

Chen Chen, Jiulong Ma, Chun Sheng Miao, Huayu Zhang, Ming Zhang, Xia Cao, Yan Shi

Phytomedicine.2021; 92: 153614. CrossRef

miRNA-483–5p Targets HDCA4 to Regulate Renal Tubular Damage in Diabetic Nephropathy

Lu Liu, Huanzhen Chen, Jie Yun, Liqun Song, Xiaopeng Ma, Shan Luo, Yexu Song

Hormone and Metabolic Research.2021; 53(08): 562. CrossRef

Rosiglitazone attenuates high glucose-induced proliferation, inflammation, oxidative stress and extracellular matrix accumulation in mouse mesangial cells through the Gm26917/miR-185-5p pathway

Dongbo Zhao, Junli Guo, Lingping Liu, Ying Huang

Endocrine Journal.2021; 68(7): 751. CrossRef

Piperazine ferulate prevents high‑glucose‑induced filtration barrier injury of glomerular endothelial cells

Yong-Yu Yang, Zhuo Chen, Xi-Ding Yang, Rong-Rong Deng, Ling-Xing Shi, Liang-Yuan Yao, Da-Xiong Xiang

Experimental and Therapeutic Medicine.2021;[Epub] CrossRef

Understanding molecular upsets in diabetic nephropathy to identify novel targets and treatment opportunities

Nidhi Raval, Akshant Kumawat, Dnyaneshwar Kalyane, Kiran Kalia, Rakesh K. Tekade

Drug Discovery Today.2020; 25(5): 862. CrossRef

AdipoRon: A Novel Insulin Sensitizer in Various Complications and the Underlying Mechanisms: A Review

Ishfaq Ahmad Bhat, Shaheen Wasil Kabeer, Mohammad Irshad Reza, Reyaz Hassan Mir, Muhammad Ovais Dar

Current Molecular Pharmacology.2020; 13(2): 94. CrossRef

Kidney-targeted baicalin-lysozyme conjugate ameliorates renal fibrosis in rats with diabetic nephropathy induced by streptozotocin

Xiao-peng Zheng, Qing Nie, Jing Feng, Xiao-yan Fan, Yue-lei Jin, Guang Chen, Ji-wei Du

Therapeutic application of nutraceuticals in diabetic nephropathy: Current evidence and future implications

Ehsan Dehdashtian, Mohammad Hossein Pourhanifeh, Karim Hemati, Saeed Mehrzadi, Azam Hosseinzadeh

Diabetes/Metabolism Research and Reviews.2020;[Epub] CrossRef

Rutin ameliorates metabolic acidosis and fibrosis in alloxan induced diabetic nephropathy and cardiomyopathy in experimental rats

Divya Ganesan, Abhishek Albert, Eldho Paul, Karthikeyan Ananthapadmanabhan, Rathinavel Andiappan, Selvam Govindan Sadasivam

Molecular and Cellular Biochemistry.2020; 471(1-2): 41. CrossRef

Psoralen alleviates high glucose-induced HK-2 cell injury by inhibition of Smad 2 signaling via upregulation of microRNA 874

Yongtao Lin, Lili Zhong, Hailun Li, Yong Xu, Xiang Li, Donghui Zheng

BMC Pharmacology and Toxicology.2020;[Epub] CrossRef

Polydatin attenuates renal fibrosis in diabetic mice through regulating the Cx32-Nox4 signaling pathway

Zhi-quan Chen, Xiao-hong Sun, Xue-juan Li, Zhan-chi Xu, Yan Yang, Ze-yuan Lin, Hai-ming Xiao, Meng Zhang, Shi-jian Quan, He-qing Huang

Acta Pharmacologica Sinica.2020; 41(12): 1587. CrossRef

High sucrose diet induces morphological, structural and functional impairments in the renal tubules of Drosophila melanogaster: A model for studying type-2 diabetes mediated renal tubular dysfunction

Lavi Rani, Sanjay Saini, Neha Shukla, Debapratim Kar Chowdhuri, Naveen Kumar Gautam

Insect Biochemistry and Molecular Biology.2020; 125: 103441. CrossRef

Renoprotective Effect of a Dipeptidyl Peptidase-4 Inhibitor on Aging Mice

Tae H Ban, Eun N Kim, Min Y Kim, Ji H Lim, Jong H Lee, Hyung D Kim, Hye E Yoon, Cheol W Park, Bum S Choi

Aging and disease.2020; 11(3): 588. CrossRef

Tannins and vascular complications of Diabetes: An update

Inhibiting the urokinase‐type plasminogen activator receptor system recovers STZ‐induced diabetic nephropathy

Massimo Dal Monte, Maurizio Cammalleri, Valeria Pecci, Monica Carmosino, Giuseppe Procino, Alessandro Pini, Mario De Rosa, Vincenzo Pavone, Maria Svelto, Paola Bagnoli

Journal of Cellular and Molecular Medicine.2019; 23(2): 1034. CrossRef

Diabetic nephropathy: An update on pathogenesis and drug development

Vikram Rao A/L B Vasanth Rao, Sean Hong Tan, Mayuren Candasamy, Subrat Kumar Bhattamisra

Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(1): 754. CrossRef

Coreopsis tinctoria Nutt ameliorates high glucose-induced renal fibrosis and inflammation via the TGF-β1/SMADS/AMPK/NF-κB pathways

Lan Yao, Jie Li, Linlin Li, Xinxia Li, Rui Zhang, Yujie Zhang, Xinmin Mao

BMC Complementary and Alternative Medicine.2019;[Epub] CrossRef

Diabetic nephropathy: The regulatory interplay between epigenetics and microRNAs

Himanshu Sankrityayan, Yogesh A. Kulkarni, Anil Bhanudas Gaikwad

Pharmacological Research.2019; 141: 574. CrossRef

CXCL6 Promotes Renal Interstitial Fibrosis in Diabetic Nephropathy by Activating JAK/STAT3 Signaling Pathway

Meng-Yao Sun, Su-Juan Wang, Xiao-Qin Li, Yu-Li Shen, Jian-Rao Lu, Xin-Hui Tian, Khalid Rahman, Li-Jun Zhang, Hua Nian, Hong Zhang

Frontiers in Pharmacology.2019;[Epub] CrossRef

Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease

International Journal of Molecular Sciences.2019; 20(7): 1782. CrossRef

Adiponectin for the treatment of diabetic nephropathy

Jun Young Lee, Jae Won Yang, Byoung Geun Han, Seung Ok Choi, Jae Seok Kim

The Korean Journal of Internal Medicine.2019; 34(3): 480. CrossRef

Piperazine ferulate ameliorates the development of diabetic nephropathy by regulating endothelial nitric oxide synthase

Yong‑Yu Yang, Ling‑Xing Shi, Jian‑He Li, Liang‑Yuan Yao, Da‑Xiong Xiang

Molecular Medicine Reports.2019;[Epub] CrossRef

Amelioration of diabetic nephropathy in db/db mice treated with tibetan medicine formula Siwei Jianghuang Decoction Powder extract

Xianrong Lai, Dong Tong, Xiaopeng Ai, Jiasi Wu, Yu Luo, Fang Zuo, Zhicheng Wei, Yanqiao Li, Wanyi Huang, Wenqian Wang, Qing Jiang, Xianli Meng, Yong Zeng, Ping Wang

Scientific Reports.2018;[Epub] CrossRef

Supplementation of Abelmoschus manihot Ameliorates Diabetic Nephropathy and Hepatic Steatosis by Activating Autophagy in Mice

Hwajin Kim, Theodomir Dusabimana, So Ra Kim, Jihyun Je, Kyuho Jeong, Min Cheol Kang, Kye Man Cho, Hye Jung Kim, Sang Won Park

Nutrients.2018; 10(11): 1703. CrossRef

Role of incretin based therapies in the treatment of diabetic kidney disease

Diabetes mellitus.2018; 21(5): 395. CrossRef

Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy

Zubair Ilyas, Joumana T. Chaiban, Armand Krikorian

Reviews in Endocrine and Metabolic Disorders.2017; 18(1): 21. CrossRef

Comment on “New therapeutic agents in diabetic nephropathy”

The Korean Journal of Internal Medicine.2017; 32(3): 569. CrossRef

Brazilin Ameliorates Diabetic Nephropathy and Inflammation in db/db Mice

Zhan-yuan Li, Yu Zheng, Yan Chen, Min Pan, Shu-bei Zheng, Wen Huang, Zhi-hong Zhou, Han-yang Ye

Inflammation.2017; 40(4): 1365. CrossRef

Response to comment on “New therapeutic agents in diabetic nephropathy”

The Korean Journal of Internal Medicine.2017; 32(3): 570. CrossRef

Treatment of diabetic kidney disease: current and future targets

The Korean Journal of Internal Medicine.2017; 32(4): 622. CrossRef